共 235 条
[1]
Amarenco P(2007)Effects of intense low-density lipoprotein cholesterol reduction in patients with Stroke or transient ischemic Attack: The Stroke Prevention by Aggressive reduction in cholesterol levels (SPARCL) trial Stroke 38 3198-3204
[2]
Goldstein LB(2018)Metabolomics and Lipidomics of ischemic Stroke Advances in Clinical Chemistry 85 31-69
[3]
Szarek M(2018)Correlated Heterospectral Lipidomics for Biomolecular Profiling of Remyelination in multiple sclerosis ACS Central Science 4 39-51
[4]
Sillesen H(2022)Early predictors of Clinical and MRI outcomes using least Absolute Shrinkage and Selection Operator (LASSO) in multiple sclerosis Annals of Neurology 92 87-96
[5]
Rudolph AE(2019)Stroke and Hypertension: An Appraisal from Pathophysiology to Clinical Practice Current Vascular Pharmacology 17 72-84
[6]
Callahan A(2018)The importance of comorbidities in ischemic Stroke: Impact of Hypertension on the cerebral circulation Journal of Cerebral Blood flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 38 2129-2149
[7]
Au A(1992)Recombinant tissue plasminogen activator in acute thrombotic and embolic Stroke Annals of Neurology 32 78-86
[8]
Bergholt MS(2021)Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson’s Disease related anxiety disorder Neuroscience Letters 745 135626-442
[9]
Serio A(2022)Epidemiology of First and recurrent ischemic Stroke in Sweden 2010–2019: A Riksstroke Study Neuroepidemiology 56 433-35
[10]
McKenzie JS(2022)Deep lipidomics in human plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation Circulation 146 21-612